Insights

Global Clinical Expertise OPIS s.r.l. operates as a comprehensive clinical CRO with over 26 years of experience managing more than 1500 studies across multiple therapeutic areas worldwide, indicating strong potential for partnerships with companies seeking experienced clinical trial support.

Diverse Service Portfolio Their full-service offerings span study design, data handling, regulatory compliance, and post-marketing investigations, providing opportunities for vendors providing specialized technologies or services to integrate into OPIS’s end-to-end solutions.

International Presence With affiliates in 18 countries, OPIS has a significant geographical footprint, making them a strategic partner for vendors offering localized regulatory, compliance, or patient recruitment solutions to support global trial execution.

Technology and Security Focus Recent partnership with DPO International for digital security highlights an emphasis on data protection, presenting opportunities for cybersecurity firms to offer advanced solutions tailored for clinical research data management.

Market Expansion Readiness OPIS’s continual growth and broad therapeutic expertise across high-demand areas such as oncology, gene therapy, and rare diseases indicate a proactive environment for introducing innovative clinical technologies, data analytics, or specialized service providers targeting advanced therapeutics.

OPIS s.r.l. Tech Stack

OPIS s.r.l. uses 8 technology products and services including WordPress, oEmbed, Indeed, and more. Explore OPIS s.r.l.'s tech stack below.

  • WordPress
    Content Management System
  • oEmbed
    Dev Tools
  • Indeed
    Human Resource Management System
  • reCAPTCHA
    Security
  • X-XSS-Protection
    Security
  • Adobe Creative Suite
    Visualisation Software
  • WPML
    Web Platform Extensions
  • AddToAny
    Widgets

OPIS s.r.l.'s Email Address Formats

OPIS s.r.l. uses at least 2 format(s):
OPIS s.r.l. Email FormatsExamplePercentage
First.Last@opis.itJohn.Doe@opis.it
95%
FirLast@opis.itJohDoe@opis.it
2%
LastFir@opis.itDoeJoh@opis.it
2%
LastFi@opis.itDoeJo@opis.it
1%
First.Last@opisresearch.comJohn.Doe@opisresearch.com
96%
First.Middle@opisresearch.comJohn.Michael@opisresearch.com
4%

Frequently Asked Questions

What is OPIS s.r.l.'s stock symbol?

Minus sign iconPlus sign icon
OPIS s.r.l. is a publicly traded company; the company's stock symbol is GPBPUSD.

What is OPIS s.r.l.'s official website and social media links?

Minus sign iconPlus sign icon
OPIS s.r.l.'s official website is opisresearch.com and has social profiles on LinkedIn.

What is OPIS s.r.l.'s NAICS code?

Minus sign iconPlus sign icon
OPIS s.r.l.'s NAICS code is 5417 - Scientific Research and Development Services.

How many employees does OPIS s.r.l. have currently?

Minus sign iconPlus sign icon
As of January 2026, OPIS s.r.l. has approximately 270 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: L. A.Chief Operating Officer: L. H.Chief Operating Officer: N. A.. Explore OPIS s.r.l.'s employee directory with LeadIQ.

What industry does OPIS s.r.l. belong to?

Minus sign iconPlus sign icon
OPIS s.r.l. operates in the Research Services industry.

What technology does OPIS s.r.l. use?

Minus sign iconPlus sign icon
OPIS s.r.l.'s tech stack includes WordPressoEmbedIndeedreCAPTCHAX-XSS-ProtectionAdobe Creative SuiteWPMLAddToAny.

What is OPIS s.r.l.'s email format?

Minus sign iconPlus sign icon
OPIS s.r.l.'s email format typically follows the pattern of First.Last@opis.it. Find more OPIS s.r.l. email formats with LeadIQ.

When was OPIS s.r.l. founded?

Minus sign iconPlus sign icon
OPIS s.r.l. was founded in 1998.

OPIS s.r.l.

Research ServicesLombardy, Italy201-500 Employees

OPIS was founded in 1998 by medical doctors from the Pharma Industry and is a global clinical CRO with 26 years of experience in a wide range of therapeutic areas. OPIS provides full-service, 360° clinical trial support from study concept creation and protocol development to full project execution, study data handling and up to study closure, analysis, and reporting. We manage Phase I-IV, interventional, non-interventional and medical device studies on an international level. In addition, OPIS also manages pre- and post-marketing clinical investigations for medical and diagnostic devices, nutraceuticals, and food supplement studies.

Our qualified, fully trained, and dedicated staff have managed more than 1500 studies.
OPIS’s strength lies in its people and its specialized teams who assist clients from A-Z with medical writing, scientific and statistical consultancy for trial design and skilled teams of operational staff that ensure high-quality project execution, with global coverage.

Our mission is to increase the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas, including oncology, cardiology, dermatology, endocrinology, gastroenterology, gene therapy, hematology, genetic diseases, hepatology, immunology, infectious diseases, musculoskeletal, dietary supplements, metabolism and nutrition disorders, nephrology, neurology, onco-hematology, ophthalmology, respiratory diseases, rare diseases, urogenital disorders and vaccines.

OPIS is committed to continuous growth and expansion, and currently we have affiliates in 18 countries around the world.

For more information, visit www.opisresearch.com
For Employment and Careers, visit www.opisresearch.com/opis-career/

Section iconCompany Overview

Stock Symbol
GPBPUSD
NAICS Code
5417 - Scientific Research and Development Services
Founded
1998
Employees
201-500

Section iconFunding & Financials

  • $10M$25M

    OPIS s.r.l.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    OPIS s.r.l.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.